Evidence map›Paper›PMID 34845256›Full record

ArticleScientific reports2021

HLA-G genetic diversity and evolutive aspects in worldwide populations.

Erick C Castelli, Bibiana S de Almeida, Yara C N Muniz, Nayane S B Silva, Marília R S Passos, Andreia S Souza, Abigail E Page, Mark Dyble, Daniel Smith, Gabriela Aguileta and 10 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Current issues in molecular biology · 2023
    Article
  15. International journal of molecular sciences · 2023
    Article
  16. Article
  17. HLA-G and Recurrent Pregnancy Loss.International journal of molecular sciences · 2023
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 4 countries.

Erick C CastelliMolecular Genetics and Bioinformatics Laboratory, Experimental Research Unit, School of Medicine, São Paulo State University (UNESP), Botucatu, State of São Paulo, Brazil. erick.castelli@unesp.br.ORCID 0000-0003-2142-7196
Bibiana S de AlmeidaDivision of Clinical Immunology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, CEP: 14049-900, Brazil.
Yara C N MunizDepartamento de Biologia Celular, Embriologia e Genética, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina (UFSC), Florianópolis, Brazil.
Nayane S B SilvaMolecular Genetics and Bioinformatics Laboratory, Experimental Research Unit, School of Medicine, São Paulo State University (UNESP), Botucatu, State of São Paulo, Brazil.
Marília R S PassosMolecular Genetics and Bioinformatics Laboratory, Experimental Research Unit, School of Medicine, São Paulo State University (UNESP), Botucatu, State of São Paulo, Brazil.
Andreia S SouzaMolecular Genetics and Bioinformatics Laboratory, Experimental Research Unit, School of Medicine, São Paulo State University (UNESP), Botucatu, State of São Paulo, Brazil.
Abigail E PageDepartment of Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Mark DybleDepartament of Anthropology, University College London (UCL), London, UK.
Daniel SmithBristol Medical School (PHS), University of Bristol, Bristol, UK.
Gabriela AguiletaDepartment of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Jaume BertranpetitDepartment of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Andrea B MiglianoDepartament of Anthropology, Unversity of Zurich, Zurich, Switzerland.
Yeda A O DuarteEscola de Enfermagem e Faculdade de Saúde Pública, Universidade de São Paulo (USP), São Paulo, State of São Paulo, Brazil.
Marília O ScliarHuman Genome and Stem Cell Research Center, Biosciences Institute, University of São Paulo (USP), São Paulo, State of São Paulo, Brazil.
Jaqueline WangHuman Genome and Stem Cell Research Center, Biosciences Institute, University of São Paulo (USP), São Paulo, State of São Paulo, Brazil.
Maria Rita Passos-BuenoHuman Genome and Stem Cell Research Center, Biosciences Institute, University of São Paulo (USP), São Paulo, State of São Paulo, Brazil.
Michel S NaslavskyHuman Genome and Stem Cell Research Center, Biosciences Institute, University of São Paulo (USP), São Paulo, State of São Paulo, Brazil.
Mayana ZatzHuman Genome and Stem Cell Research Center, Biosciences Institute, University of São Paulo (USP), São Paulo, State of São Paulo, Brazil.
Celso Teixeira Mendes-JuniorDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, 14040-901, Ribeirão Preto, SP, Brazil.
Eduardo A DonadiDivision of Clinical Immunology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, CEP: 14049-900, Brazil. eadonadi@fmrp.usp.br.
Universidade de São Paulo · BRUniversidade Estadual Paulista (Unesp) · BRUniversidade de Ribeirão Preto · BRUniversitat Pompeu Fabra · ESLondon School of Hygiene & Tropical Medicine · GBUniversidade Federal de Santa Catarina · BRUniversity College London · GBUniversity of Bristol · GBUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HLA-G is a promiscuous immune checkpoint molecule. The HLA-G gene presents substantial nucleotide variability in its regulatory regions. However, it encodes a limited number of proteins compared to classical HLA class I genes. We characterized the HLA-G genetic variability in 4640 individuals from 88 different population samples across the globe by using a state-of-the-art method to characterize polymorphisms and haplotypes from high-coverage next-generation sequencing data. We also provide insights regarding the HLA-G genetic diversity and a resource for future studies evaluating HLA-G polymorphisms in different populations and association studies. Despite the great haplotype variability, we demonstrated that: (1) most of the HLA-G polymorphisms are in introns and regulatory sequences, and these are the sites with evidence of balancing selection, (2) linkage disequilibrium is high throughout the gene, extending up to HLA-A, (3) there are few proteins frequently observed in worldwide populations, with lack of variation in residues associated with major HLA-G biological properties (dimer formation, interaction with leukocyte receptors). These observations corroborate the role of HLA-G as an immune checkpoint molecule rather than as an antigen-presenting molecule. Understanding HLA-G variability across populations is relevant for disease association and functional studies.

Indexed as

Polymorphism, Genetic3' Untranslated RegionsAllelesComputational BiologyDimerizationEvolution, MolecularGene FrequencyGenes, MHC Class IGenetics, PopulationGenetic VariationGenotypeGlobal HealthHaplotypesHigh-Throughput Nucleotide SequencingHLA-G AntigensHumans3' Untranslated RegionsHLA-G AntigensImmune Checkpoint Proteins

Identifiers

PMID34845256
PMCPMC8629979
OpenAlexW3215846188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.